170 related articles for article (PubMed ID: 30270002)
1. Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.
Beyett TS; Gan X; Reilly SM; Gomez AV; Chang L; Tesmer JJG; Saltiel AR; Showalter HD
Bioorg Med Chem; 2018 Nov; 26(20):5443-5461. PubMed ID: 30270002
[TBL] [Abstract][Full Text] [Related]
2. Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKK
Beyett TS; Gan X; Reilly SM; Chang L; Gomez AV; Saltiel AR; Showalter HD; Tesmer JJG
Mol Pharmacol; 2018 Oct; 94(4):1210-1219. PubMed ID: 30082428
[TBL] [Abstract][Full Text] [Related]
3. The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.
Möller M; Wasel J; Schmetzer J; Weiß U; Meissner M; Schiffmann S; Weigert A; Möser CV; Niederberger E
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630674
[TBL] [Abstract][Full Text] [Related]
4. Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1.
Mowers J; Uhm M; Reilly SM; Simon J; Leto D; Chiang SH; Chang L; Saltiel AR
Elife; 2013 Dec; 2():e01119. PubMed ID: 24368730
[TBL] [Abstract][Full Text] [Related]
5. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
Zhou Z; Qi J; Lim CW; Kim JW; Kim B
Toxicology; 2020 Nov; 444():152579. PubMed ID: 32905826
[TBL] [Abstract][Full Text] [Related]
6. Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases.
Wang T; Block MA; Cowen S; Davies AM; Devereaux E; Gingipalli L; Johannes J; Larsen NA; Su Q; Tucker JA; Whitston D; Wu J; Zhang HJ; Zinda M; Chuaqui C
Bioorg Med Chem Lett; 2012 Mar; 22(5):2063-9. PubMed ID: 22305584
[TBL] [Abstract][Full Text] [Related]
7. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation.
Clark K; Plater L; Peggie M; Cohen P
J Biol Chem; 2009 May; 284(21):14136-46. PubMed ID: 19307177
[TBL] [Abstract][Full Text] [Related]
8. Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice.
Zhou Z; Qi J; Zhao J; Lim CW; Kim JW; Kim B
J Cell Mol Med; 2020 Jan; 24(2):1383-1398. PubMed ID: 31821710
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases.
McIver EG; Bryans J; Birchall K; Chugh J; Drake T; Lewis SJ; Osborne J; Smiljanic-Hurley E; Tsang W; Kamal A; Levy A; Newman M; Taylor D; Arthur JS; Clark K; Cohen P
Bioorg Med Chem Lett; 2012 Dec; 22(23):7169-73. PubMed ID: 23099093
[TBL] [Abstract][Full Text] [Related]
10. Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor.
Lefranc J; Schulze VK; Hillig RC; Briem H; Prinz F; Mengel A; Heinrich T; Balint J; Rengachari S; Irlbacher H; Stöckigt D; Bömer U; Bader B; Gradl SN; Nising CF; von Nussbaum F; Mumberg D; Panne D; Wengner AM
J Med Chem; 2020 Jan; 63(2):601-612. PubMed ID: 31859507
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.
Reilly SM; Chiang SH; Decker SJ; Chang L; Uhm M; Larsen MJ; Rubin JR; Mowers J; White NM; Hochberg I; Downes M; Yu RT; Liddle C; Evans RM; Oh D; Li P; Olefsky JM; Saltiel AR
Nat Med; 2013 Mar; 19(3):313-21. PubMed ID: 23396211
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 6-aryl-azabenzimidazoles that inhibit the TBK1/IKK-ε kinases.
Johannes JW; Chuaqui C; Cowen S; Devereaux E; Gingipalli L; Molina A; Wang T; Whitston D; Wu X; Zhang HJ; Zinda M
Bioorg Med Chem Lett; 2014 Feb; 24(4):1138-43. PubMed ID: 24462666
[TBL] [Abstract][Full Text] [Related]
13. FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.
Reilly SM; Abu-Odeh M; Ameka M; DeLuca JH; Naber MC; Dadpey B; Ebadat N; Gomez AV; Peng X; Poirier B; Walk E; Potthoff MJ; Saltiel AR
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822771
[TBL] [Abstract][Full Text] [Related]
14. Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
Cruz VH; Arner EN; Wynne KW; Scherer PE; Brekken RA
Mol Metab; 2018 Oct; 16():139-149. PubMed ID: 29935921
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.
Oral EA; Reilly SM; Gomez AV; Meral R; Butz L; Ajluni N; Chenevert TL; Korytnaya E; Neidert AH; Hench R; Rus D; Horowitz JF; Poirier B; Zhao P; Lehmann K; Jain M; Yu R; Liddle C; Ahmadian M; Downes M; Evans RM; Saltiel AR
Cell Metab; 2017 Jul; 26(1):157-170.e7. PubMed ID: 28683283
[TBL] [Abstract][Full Text] [Related]
16. Development of a high-throughput assay for identifying inhibitors of TBK1 and IKKε.
Hutti JE; Porter MA; Cheely AW; Cantley LC; Wang X; Kireev D; Baldwin AS; Janzen WP
PLoS One; 2012; 7(7):e41494. PubMed ID: 22859992
[TBL] [Abstract][Full Text] [Related]
17. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell.
He Q; Xia X; Yao K; Zeng J; Wang W; Wu Q; Tang R; Zou X
Life Sci; 2019 Dec; 239():117010. PubMed ID: 31672578
[TBL] [Abstract][Full Text] [Related]
18. Amlexanox ameliorates acetaminophen-induced acute liver injury by reducing oxidative stress in mice.
Qi J; Zhou Z; Lim CW; Kim JW; Kim B
Toxicol Appl Pharmacol; 2019 Dec; 385():114767. PubMed ID: 31697998
[TBL] [Abstract][Full Text] [Related]
19. Structure and ubiquitination-dependent activation of TANK-binding kinase 1.
Tu D; Zhu Z; Zhou AY; Yun CH; Lee KE; Toms AV; Li Y; Dunn GP; Chan E; Thai T; Yang S; Ficarro SB; Marto JA; Jeon H; Hahn WC; Barbie DA; Eck MJ
Cell Rep; 2013 Mar; 3(3):747-58. PubMed ID: 23453972
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TBK1 by amlexanox attenuates paraquat-induced acute lung injury.
Wang N; Li Y; Wang X; Ma Z; Wang Y; Zhang C; Yuan Y; Zhao M
Toxicology; 2020 Oct; 443():152555. PubMed ID: 32763286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
